Navigation Links
Diplomat Specialty Pharmacy 2011 Patient Satisfaction Survey Results Affirm Success of Company's Patient Focused Model
Date:6/30/2011

FLINT, Mich., June 30, 2011 /PRNewswire/ -- Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, revealed the results of its annual patient satisfaction survey today.  The survey, conducted by Gartner & Associates LLC in May 2011, reaffirms Diplomat's industry leading patient satisfaction rates.

Key survey findings reflect:

  • 99% of customer respondents were satisfied overall with Diplomat
  • 98% indicated that Diplomat meets their expectations
  • 90% indicated that Diplomat exceeds their expectations

The written survey was mailed May 11, 2011 by Diplomat to a random sample of 1,545 customers, following the same Gartner-developed methodology used in the spring 2010 survey – which also reflected outstanding levels of patient satisfaction. 463 surveys were returned, representing an impressive 30% response rate.

Diplomat Specialty Pharmacy President and CEO Phil Hagerman, R.Ph., says the overwhelmingly positive 2011 survey results affirm the Company's patient focused model, which remained constant during the Company's unprecedented growth over the past several years.

"This type of customer-provided data reinforces the importance and value of our Company approach, which includes direct outreach to patients to maintain our high adherence rates and our proprietary eNAV® IT platform," notes Hagerman.

"Equally important, the survey results reflect positive patient feedback at a time when Diplomat is on a major growth spurt, nearly 50% year over year.  On top of that, we moved our entire operation to a new 350,000 square foot facility, however we didn't sacrifice patient satisfaction for increased revenues, more patients and a larger operation center and that's tremendously gratifying to all of us at Diplomat."

The eNAV® system plays a vital role in patient compliance, evidenced by the fact that Diplomat's specialty patients average better than 90% adherence to their medications, while the national average is 50-70% for chronic medicines. 

About Diplomat Specialty Pharmacy

Michigan-based Diplomat Specialty Pharmacy, founded in 1975, is the nation's largest privately held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's, Hemophilia, Growth Hormone and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Therapy and Specialty Compounding.  Locations include: Flint and Grand Rapids, MI; Chicago, IL; Ft. Lauderdale, FL; and San Bernardino, CA. Learn more about Keeping Patients Healthier…Longer® at www.diplomatpharmacy.com.


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Diplomat Specialty Pharmacys Hagerman Named Grant Thornton Leader & Innovator of the Year
2. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
3. Diplomat Specialty Pharmacy Honored by Inc. Magazine as One of the Nations Fastest-Growing Companies
4. Diplomat Specialty Pharmacy Hires Senior Director of HR & Government Relations
5. Diplomat Specialty Pharmacy Hires Vice President of Operations
6. Southwest Oncology Network (SWON) Selects Diplomat Specialty Pharmacy for Development and Launch of SWON-Rx, an Oral Oncology Medication Management Platform
7. Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California
8. Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)
9. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
10. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
11. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec 9, 2016 Research and Markets has ... report to their offering. ... The global travel vaccines market to grow at ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the sales of various ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare Properties ... by an affiliate of Seavest, has won a prestigious national healthcare real estate ... ambulatory care center (ACC) was named “Best New Development, MOBs and Other Outpatient ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, ... Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related to ... prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 with ...
Breaking Medicine News(10 mins):